Figure 2
Figure 2. Distribution of scores as assigned by the HCT-CI to nonmyeloablative compared with myeloablative patients with lymphoma or CLL.

Distribution of scores as assigned by the HCT-CI to nonmyeloablative compared with myeloablative patients with lymphoma or CLL.

Close Modal
This Feature Is Available To Subscribers Only

or Create an Account

Close Modal
Close Modal